JAMP Pharma Group launches PrPexegra®, a biosimilar alternative to the reference product PrNeulasta® (commercialized in ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it ...

Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.

A recent study reveals that rheumatoid arthritis (RA) begins years before joint pain manifests, with the immune system ...

CCISD says preliminary report on Yeager Elementary building shaking incident still not ready despite occurring in Early January 2025.

Despite its low cost and low toxicity, bismuth has found limited applications in organic synthesis. Liam Ball is working to ...

RDE is a propulsion system that promises higher power, greater fuel efficiency, and lower emissions than conventional rocket ...

The battery capacity increased by approximately 25%, and the driving range increased by nearly 150 kilometers. In September 2025, the Japanese electronics giant Panasonic announced that it is expected ...

In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, describes how double-blind double-dummy design, site reminders, and ...

This review analyzes nearly three decades of research on menstrual cycle phases and their inconsistent effects on women's ...

An oral GLP-1 induced significantly greater weight loss than placebo for adults with obesity or overweight plus one ...